Skip to main content

Table 1 Patient characteristics of mutant and wild-type IDH groups

From: Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy

Characteristic

Number of patients (%)

pvalue

 

MutantIDH

Wild-typeIDH

 

Number

25

27

 

Men: Women

14:11

14:13

 

Age (years)

   

Median

45

61

0.0008*

Range

26-67

28-77

 

Newly diagnosed

22 (88.0)

25 (92.6)

0.9279

Recurrent

3 (12.0)

2 (7.4)

 

Pathological grade

   

WHO Grade II

17 (68.0)

7 (25.9)

0.0024*

WHO Grade III

8 (32.0)

20 (74.1)

 

Outcome

   

Alive

20 (80.0)

12 (44.4)

0.0085*

Dead

5 (20.0)

15 (55.6)

 
  1. Results of unpaired t-test (age) and chi-squared tests (others). The values inside parentheses represent percentage of patients within each group.
  2. *p <0.05.
  3. IDH: isocitrate dehydrogenase; WHO: World Health Organization.
Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us